NLST中 Lung-RADS 3类病灶的临床意义
基于NLST数据库,分析1763个Lung-RADS 3类病灶(占低剂量CT参与者的6.6%),7年内肺癌发生率为6.1%、肺癌特异性死亡为2.3%。早期诊断组肺癌和LSD率高于年度筛查组;若取消6个月CT,估计LSD增加所有3类患者的0.6%。高龄、肺气肿和>5mm部分实性结节与肺癌风险相关。
要点
- Lung-RADS 3类病灶占低剂量CT参与者的6.6%,7年肺癌率6.1%、LSD 2.3%。
- 早期诊断组肺癌率7.5% vs 年度组3.1%,LSD 4.0% vs 1.0%。
- 取消6个月CT估计增加LSD 0.6%(占所有LSD的24.4%)。
核心结论
- Lung-RADS 3类病灶不常见,取消6个月CT可能增加所有3类患者的LSD 0.6%。
- 高龄、肺气肿和>5mm部分实性结节可能有助于预测3类患者肺癌风险。
研究设计与样本
- 基于NLST数据库,识别基线筛查为Lung-RADS 3类病灶的参与者。
- 比较6个月前首次随访CT(早期诊断组)与年度筛查(年度诊断组)的肺癌率和LSD。
- 回归分析寻找3类病灶中发生肺癌的相关特征。
主要发现
- 共1763个3类病灶,占所有低剂量CT参与者的6.6%。
- 7年内108例肺癌(6.1%)和41例LSD(2.3%)。
- 早期诊断组肺癌率7.5% vs 年度组3.1%,LSD 4.0% vs 1.0%。
- 若不做6个月CT,估计LSD增加所有3类患者的0.6%(占所有LSD的24.4%)。
- 多因素回归显示高龄、肺气肿和>5mm部分实性结节与肺癌发生相关。
临床怎么用
- Lung-RADS 3类患者应按指南进行6个月CT随访,取消可能增加LSD。
- 对高龄、肺气肿或>5mm部分实性结节的3类患者可考虑更密切随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: To determine the clinical significance of category 3 (CAT3) abnormalities and the necessity of a 6-month follow-up computed tomography (CT). We also explored features associated with increased lung cancer risk. METHODS: From the National Lung Screening Trial database, we identified participants with CAT3 lesions at prevalence screen. Rates of lung cancer and lung cancer-specific deaths (LSDs) were compared between those who underwent first follow-up CT before 6 months (early diagnostic group) and those who underwent annual screening (annual diagnostic group). We estimated the change in LSD if the 6-month CT was eliminated. Regression analysis was performed to identify features associated with participants with CAT3 who developed lung cancer. RESULTS: A total of 1763 CAT3s were identified (6.6% of all participants who had low-dose CT), with 108 lung cancers (6.1%) and 41 LSDs (2.3%) in a 7-year period. Rates of lung cancer (7.5% versus 3.1%) and LSD (4.0% versus 1.0%) were higher in the early diagnostic group than in the annual diagnostic group. We estimated an increase in LSD of 0.6% of all participants with CAT3 (24.4% of all LSDs) if the 6-month CT was not performed. Multivariate regression analysis found that increased age, emphysema, and a part-solid nodule greater than 5 mm were associated with participants with CAT3 who developed lung cancer. CONCLUSIONS: CAT3 lesions are uncommon, and eliminating the 6-month CT would potentially increase LSD by 0.6% of all patients with CAT3. Age, emphysema, and part-solid nodule greater than 5 mm may be useful in risk prediction models to determine which participants with CAT3 are more likely to develop lung cancer and suggest which patients may need more intense follow-up.
引用
- Han DH, Duan F, Wu Y, et al. Clinical Significance of Lung-RADS Category 3 Lesions in the National Lung Screening Trial. J Thorac Oncol. 2021. PMID: 33722708. doi:10.1016/j.jtho.2021.02.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。